证券代码：600141 证券简称：兴发集团 公告编号：临2025-033 转债代码：110089 转债简称：兴发转债 2025 年 6 月5 日 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演APP， 参与本次互动交流，活动时间为2025 年 6 月 12 日（周四）14:00-16:40。届 时公司高管将在线就公司 2024 年度业绩、公司治理、发展战略、经营状况等 投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与。 特此公告。 湖北兴发化工集团股份有限公司 董事会 湖北兴发化工集团股份有限公司 关于参加湖北辖区上市公司 2025 年投资者网上集体接待日 活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强与投资者的互动交流，湖北兴发化工集团股份有限公司（以 下简称"公司"）将参加由湖北证监局、湖北省上市公司协会与深圳市全景网 络有限公司联合举办的"2025 年湖北辖区上市公司投资者集 ...

Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company reported Q1 2025 revenue of 7.23 billion yuan, a year-on-year increase of 4.9%, but a net profit attributable to shareholders of 310 million yuan, down 18.6% year-on-year [2][5] - The decline in product prices has put pressure on the company's performance, with significant decreases in the sales prices of key products such as glyphosate and organic silicon [11] - The company is expected to benefit from a recovery in product prices and the successful launch of new projects, which will enhance its profitability [11] - The company plans to distribute a cash dividend of 10 yuan per 10 shares, totaling 1.1 billion yuan, which represents a 66.7% increase year-on-year [11] Financial Performance - In Q1 2025, the company's gross margin was 12.9%, down 1.5 percentage points year-on-year, and the net margin was 4.6%, down 0.9 percentage points year-on-year [11] - The company has a production capacity of 230,000 tons per year for glyphosate and 600,000 tons per year for organic silicon, with both products currently at historical low price levels [11] - The company expects net profits attributable to shareholders to be 1.93 billion yuan, 2.53 billion yuan, and 2.94 billion yuan for 2025, 2026, and 2027 respectively [11]

Core Viewpoint - The announcement details the share purchase by the company's supervisor, Zheng Lei, reflecting confidence in the company's long-term investment value [1][2]. Group 1: Share Purchase Details - Zheng Lei purchased 15,000 A-shares on May 23, 2025, for a total amount of 311,530 yuan, which represents 0.0014% of the company's total share capital [1]. - Prior to the purchase, Zheng Lei held 40,000 shares, indicating a significant personal investment in the company [1]. Group 2: Compliance and Regulations - The share purchase complies with relevant laws and regulations, including the Securities Law and the Shanghai Stock Exchange listing rules [1][2]. - Zheng Lei has committed to not selling the shares acquired for a period of six months following the purchase [2]. - The company will manage the shares according to the regulations set by the China Securities Regulatory Commission and the Shanghai Stock Exchange [2].

本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 转债代码：110089 转债简称：兴发转债 证券代码：600141 证券简称：兴发集团 公告编号：临 2025-032 湖北兴发化工集团股份有限公司 关于监事增持公司股份公告 | 增持主体名称 | 郑磊 | | | | | --- | --- | --- | --- | --- | | 增持股份种类 | A 股 | | | | | 增持股份实施期间 | 2025 年 | 5 | 月 | 23 日 | | 增持股份对应方式及数量 | | 集中竞价，15,000 | | 股 | | 增持股份金额 | 311,530 | | | 元（不含交易费用） | | 增持股份比例（占总股本） | 0.0014% | | | | | 增持完成后增持主体(及其一致 | 55,000 | 股 | | | | 行动人)持股数量 | | | | | | 增持完成后增持主体（及其一致 | 0.0050% | | | | | 行动人）持股比例 | | | | | （三）公司监事郑磊先 ...

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [8]. Core Views - The company is expected to see significant profit growth driven by new production capacity, with forecasts for net profits of 1.628 billion, 1.867 billion, and 2.138 billion yuan for 2025, 2026, and 2027 respectively [8]. - The company emphasizes investor returns, with a cash dividend of 1 yuan per share for 2024, resulting in a dividend yield of 4.61% [4][8]. - The company is actively managing its market value and has seen its second-largest shareholder increase their stake by 220 million to 440 million yuan [2]. Summary by Sections Financial Performance - In Q1 2025, the company reported revenue of 7.228 billion yuan, a year-on-year increase of 4.94% and a quarter-on-quarter increase of 13.90%. However, the net profit attributable to shareholders was 311 million yuan, down 18.61% year-on-year but up 8.19% quarter-on-quarter [1][2]. Production Capacity and Projects - The company is set to launch a new phosphate mine project with an annual capacity of 4 million tons in 2025, which is expected to be a new profit growth driver [2]. - Current production capacity includes over 160,000 tons/year of yellow phosphorus and 32,000 tons/year of flame retardants, with ongoing projects to enhance these capacities [2]. Cost Management - The company has seen a decrease in its R&D expense ratio to 3.05%, while the financial expense ratio has slightly increased to 1.38% [3]. Market Position and Shareholder Engagement - The company is focused on enhancing its core competitiveness and providing consistent, high-level cash dividends to investors [7]. - The stock price is currently at 20.67 yuan, with a total market capitalization of 22.8 billion yuan [4].

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [8]. Core Insights - The company reported a revenue of 7.228 billion yuan in Q1 2025, reflecting a year-on-year increase of 4.94% and a quarter-on-quarter increase of 13.90%. However, the net profit attributable to shareholders was 311 million yuan, showing a year-on-year decline of 18.61% but a quarter-on-quarter increase of 8.19% [1]. - A new phosphate mining project with an annual capacity of 4 million tons is expected to commence production in 2025, which will serve as a new profit growth point for the company [2]. - The company is focusing on enhancing shareholder returns, with a cash dividend of 1 yuan per share for 2024, resulting in a dividend yield of 4.61% [4]. - The company has a strong market position in yellow phosphorus production, with an annual capacity exceeding 160,000 tons, and is advancing in the commercialization of black phosphorus products [2]. - The company is also managing its market value effectively, with its second-largest shareholder planning to increase holdings by 220 million to 440 million yuan [2]. Financial Summary - The company’s sales expense ratio for Q1 2025 was 0.79%, a decrease of 0.32 percentage points year-on-year and 0.90 percentage points quarter-on-quarter. The management expense ratio was 4.35%, showing a slight increase of 0.05 percentage points year-on-year but a decrease of 4.48 percentage points quarter-on-quarter. The financial expense ratio was 1.38%, up 0.09 percentage points year-on-year and 0.20 percentage points quarter-on-quarter. The R&D expense ratio was 3.05%, down 0.03 percentage points year-on-year and 2.36 percentage points quarter-on-quarter [3]. - The company forecasts net profits attributable to shareholders of 1.628 billion yuan in 2025, 1.867 billion yuan in 2026, and 2.138 billion yuan in 2027, with corresponding price-to-earnings ratios of 14.0, 12.2, and 10.7 times [8].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected investment return that will outperform the market benchmark by more than 15% over the next 6-12 months [12]. Core Views - The company reported a revenue of 28.396 billion yuan for 2024, a year-on-year increase of 0.41%, and a net profit attributable to shareholders of 1.601 billion yuan, up 14.33% year-on-year [4][6]. - The agricultural chemical market is showing signs of recovery, contributing to stable performance in profitability throughout the year [6]. - The company has adjusted its production and sales strategies, leading to significant increases in operating rates and sales volumes across its main products [9]. Summary by Sections Financial Performance - In Q1 2025, the company achieved a revenue of 7.228 billion yuan, a year-on-year increase of 4.94% and a quarter-on-quarter increase of 13.90% [5]. - For Q4 2024, the company reported a revenue of 6.346 billion yuan, a year-on-year increase of 1.70% but a quarter-on-quarter decrease of 26.60% [8]. Product Performance - The company’s main product segments, including specialty chemicals, fertilizers, pesticides, and organic silicon, generated revenues of 5.278 billion, 4.049 billion, 5.204 billion, and 2.647 billion yuan respectively in 2024, with year-on-year growth rates of 4.97%, 12.26%, 21.50%, and 23.48% [6]. - The average market prices for key products in 2024 were as follows: glyphosate at 25,049.75 yuan/ton (down 22.96%), phosphate rock at 1,013.52 yuan/ton (up 2.36%), and DMC at 13,987.6 yuan/ton (down 6.34%) [7]. Strategic Initiatives - The company invested 1.188 billion yuan in R&D in 2024, focusing on technological innovations and project advancements to support its transition to a green chemical new materials enterprise [11]. - Key projects such as the 1 million tons/year optical selection mining project and the 200,000 tons/year phosphate rock selection project have commenced operations, enhancing the company's resource utilization [11]. Future Outlook - The company is expected to achieve net profits of 1.825 billion, 2.078 billion, and 2.366 billion yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 13, 11, and 10 [12].

证券代码：600141 证券简称：兴发集团 公告编号：临2025-030 转债代码：110089 转债简称：兴发转债 湖北兴发化工集团股份有限公司 2025 年员工持股计划第一次持有人会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 常监督和管理机构，代表持有人行使股东权利。管理委员会由5 名委员组成， 设管理委员会主任1 名。管理委员会委员的任期为本次员工持股计划的存续期。 表决结果：同意212,538,000 份，占出席持有人会议的持有人所持份额总 数的100%；反对0 份；弃权0 份；回避0 份。 （二）审议通过了《关于选举公司2025 年员工持股计划管理委员会委员 的议案》 经审议表决，选举朱艳、胡秀丽、刘红燕、万瑾、胡玲玲为公司2025 年 员工持股计划管理委员会委员，朱艳为管理委员会主任，任期与2025 年员工 持股计划的存续期一致。管理委员会委员与公司控股股东、实际控制人、董事、 监事、高级管理人员不存在关联关系。 表决结果：同意211,218,000 份，占出席持有人会议的持有人所持份额总 数 ...

证券代码：600141 证券简称：兴发集团 公告编号：临2025-031 转债代码：110089 转债简称：兴发转债 湖北兴发化工集团股份有限公司 关于 2025 年员工持股计划购买完成的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北兴发化工集团股份有限公司（以下简称"公司"）分别于 2025 年3 月29 日、2025 年4 月24 日召开第十一届董事会第七次会议和2024 年度股东 会，审议通过了《关于2025 年员工持股计划（草案）及其摘要的议案》《关 于2025 年员工持股计划管理办法的议案》《关于提请股东会授权董事会办理 公司2025 年员工持股计划相关事宜的议案》等相关议案，具体内容详见公司 分别于 2025 年 4 月 1 日、2025 年 4 月 25 日在上海证券交易所网站 (http://www.sse.com.cn)披露的相关公告。 根据中国证监会《关于上市公司实施员工持股计划试点的指导意见》及《上 海证券交易所上市公司自律监管指引第1号——规范运作(2023 年12月修订）》 等法律法 ...

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Views - The company's Q1 2025 performance met expectations, with total revenue of 7.228 billion yuan, a year-on-year increase of 5%, and a net profit attributable to shareholders of 311 million yuan, a year-on-year decrease of 19% [6] - The decline in profitability is attributed to falling prices of key products such as diammonium phosphate and glyphosate, alongside an 80% increase in sulfur procurement costs [6] - The company is expected to benefit from potential changes in export policies for fertilizers, which could lead to a recovery in profitability [6] - The special chemicals segment continues to grow, with a 12% increase in sales volume in Q1 2025, indicating a positive trend in the company's transformation and upgrade efforts [6] Financial Data and Profit Forecast - Projected total revenue for 2025 is 29.364 billion yuan, with a year-on-year growth rate of 3.4% [5] - The forecasted net profit attributable to shareholders for 2025 is 1.823 billion yuan, reflecting a year-on-year increase of 13.8% [5] - The company's earnings per share (EPS) is expected to be 1.65 yuan for 2025, with a corresponding price-to-earnings (PE) ratio of 12 [5] - The gross margin is projected to improve to 20% by 2025, up from 12.9% in Q1 2025 [5]